Safety & Science
Evidence-based menopause care, reviewed by specialists, dispensed by FDA-registered pharmacies.
The 2002 Women's Health Initiative (WHI) study created a generation of fear around hormone replacement therapy. Subsequent research — and a closer reading of the original data — has dramatically changed the medical understanding of who benefits from HRT and at what risk level.
The North American Menopause Society (NAMS) now recommends hormone therapy for most healthy women under 60 or within 10 years of menopause onset, citing evidence that for this population, benefits typically outweigh risks.
Bioidentical hormones — estradiol and progesterone structurally identical to the ones your body produces — have a different risk profile than the synthetic hormones used in the original WHI study population. Modern prescribing is based on individualized risk assessment, not a single 20-year-old headline.
This page summarizes current medical consensus. It is not medical advice. Your physician will evaluate whether treatment is appropriate for you based on your complete health profile.
Early access
Join the early access list. We'll reach out the moment Lueur launches.
No spam. Unsubscribe anytime.